A detailed history of Citigroup Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 66,025 shares of LNTH stock, worth $6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,025
Previous 34,275 92.63%
Holding current value
$6 Million
Previous $2.75 Million 163.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$77.7 - $123.62 $2.47 Million - $3.92 Million
31,750 Added 92.63%
66,025 $7.25 Million
Q2 2024

Aug 12, 2024

BUY
$58.87 - $83.05 $231,653 - $326,801
3,935 Added 12.97%
34,275 $2.75 Million
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $353,864 - $472,973
6,929 Added 29.6%
30,340 $1.89 Million
Q4 2023

Feb 09, 2024

SELL
$55.6 - $77.89 $180,811 - $253,298
-3,252 Reduced 12.2%
23,411 $1.45 Million
Q3 2023

Nov 09, 2023

SELL
$60.27 - $90.75 $1.42 Million - $2.13 Million
-23,523 Reduced 46.87%
26,663 $1.85 Million
Q2 2023

Aug 10, 2023

SELL
$82.41 - $99.65 $278,793 - $337,115
-3,383 Reduced 6.32%
50,186 $4.21 Million
Q1 2023

May 11, 2023

BUY
$47.76 - $82.86 $1.68 Million - $2.91 Million
35,135 Added 190.6%
53,569 $4.42 Million
Q4 2022

Feb 09, 2023

SELL
$48.76 - $77.67 $1.11 Million - $1.76 Million
-22,716 Reduced 55.2%
18,434 $939,000
Q3 2022

Nov 10, 2022

BUY
$61.42 - $86.29 $145,811 - $204,852
2,374 Added 6.12%
41,150 $2.9 Million
Q2 2022

Aug 10, 2022

SELL
$55.54 - $72.65 $1.22 Million - $1.6 Million
-21,999 Reduced 36.2%
38,776 $2.56 Million
Q1 2022

May 12, 2022

BUY
$24.28 - $56.64 $207,132 - $483,195
8,531 Added 16.33%
60,775 $3.36 Million
Q4 2021

Feb 10, 2022

BUY
$22.54 - $30.44 $186,856 - $252,347
8,290 Added 18.86%
52,244 $1.51 Million
Q3 2021

Nov 10, 2021

BUY
$24.23 - $28.59 $1.07 Million - $1.26 Million
43,954 New
43,954 $1.13 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.25B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.